Clinical Trial Update: Use of Machine-learning Algorithms, Biomarkers and Measures of Quality of Life to Personalize Medical Management of Liver and Heart Transplant Recipients

View source ↗

Summary

Clinical trial update on using machine-learning, biomarkers, and quality-of-life measures to personalize care for liver and heart transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Artificial Intelligence (AI), Hepatocellular Carcinoma (HCC) | Status: NOT_YET_RECRUITING